Shenzhen New Industries Biomedical Engineering Co., Ltd. (SHE:300832)

SHE:300832 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	651.09	919.53	1,048	483.43	617.58	1,075
Short-Term Investments	-	-	275.79	110.09	-	-
Trading Asset Securities	1,827	1,723	2,080	2,814	2,806	2,300
Cash & Short-Term Investments	2,478	2,643	3,404	3,407	3,424	3,375
Cash Growth	-24.95%	-22.36%	-0.09%	-0.49%	1.46%	70.44%
Accounts Receivable	1,099	957.49	631.78	479.97	276.1	218.35
Other Receivables	8.9	147.98	80.66	42.83	12.69	2.77
Receivables	1,108	1,105	712.44	522.79	288.79	221.13
Inventory	1,117	1,198	916.79	839.33	645.38	459.29
Prepaid Expenses	-	23.72	7.44	32.29	104.75	48.32
Other Current Assets	311.55	85.75	23.09	20.8	34.16	21.48
Total Current Assets	5,015	5,056	5,064	4,822	4,497	4,125
Property, Plant & Equipment	1,750	1,694	1,442	1,325	1,134	803.51
Long-Term Investments	2,005	1,926	924.95	357.62	136.9	-
Other Intangible Assets	244.13	245.06	169.46	172.48	94.56	98.91
Long-Term Accounts Receivable	-	310.8	189.17	93.85	28.1	-
Long-Term Deferred Tax Assets	69.26	63.98	37.94	22.9	12.14	22.73
Long-Term Deferred Charges	143.63	150.83	156.69	69.08	74.97	77.56
Other Long-Term Assets	502.17	173.35	238.22	150.77	157.39	178.06
Total Assets	9,729	9,619	8,222	7,015	6,136	5,306
Accounts Payable	249.41	456.62	126.99	176.68	171.35	98.26
Accrued Expenses	59.3	200.59	187.77	149.03	124.27	121.78
Current Portion of Leases	1.34	1.34	1.69	1.32	1.35	-
Current Income Taxes Payable	169.19	120.14	120.35	76.19	59.92	95.9
Current Unearned Revenue	51.82	80.13	91.48	108.94	77.08	71.06
Other Current Liabilities	64.78	49.91	63.2	71.78	73.96	105.74
Total Current Liabilities	595.83	908.74	591.48	583.94	507.94	492.74
Long-Term Leases	2.54	2.76	3.49	0.89	0.88	-
Long-Term Unearned Revenue	45.57	47.26	33.06	5.81	6.58	8.74
Long-Term Deferred Tax Liabilities	75.51	78.51	50.06	24.41	8.11	-
Other Long-Term Liabilities	5.95	5.58	-	-	-	-
Total Liabilities	725.4	1,043	678.09	615.06	523.51	501.49
Common Stock	785.72	785.72	785.72	786.13	786.66	412.35
Additional Paid-In Capital	1,332	1,332	1,332	1,348	1,450	1,601
Retained Earnings	6,854	6,417	5,374	4,267	3,411	2,850
Treasury Stock	-	-	-	-16.29	-37.51	-58.55
Comprehensive Income & Other	31.46	41.72	52.7	13.99	1.64	-0.33
Shareholders' Equity	9,004	8,577	7,544	6,399	5,612	4,804
Total Liabilities & Equity	9,729	9,619	8,222	7,015	6,136	5,306
Total Debt	3.88	4.1	5.18	2.22	2.24	-
Net Cash (Debt)	2,474	2,639	3,399	3,405	3,422	3,375
Net Cash Growth	-24.96%	-22.36%	-0.17%	-0.49%	1.40%	70.44%
Net Cash Per Share	3.15	3.36	4.33	4.33	4.35	4.50
Filing Date Shares Outstanding	785.72	785.72	785.72	786.13	786.66	783.47
Total Common Shares Outstanding	785.72	785.72	785.72	786.13	786.66	783.47
Working Capital	4,419	4,147	4,473	4,238	3,989	3,632
Book Value Per Share	11.46	10.92	9.60	8.14	7.13	6.13
Tangible Book Value	8,760	8,332	7,375	6,227	5,517	4,705
Tangible Book Value Per Share	11.15	10.60	9.39	7.92	7.01	6.01
Buildings	-	1,061	1,061	541.55	516.8	504.42
Machinery	-	811.8	659.08	512.48	427.32	313.43
Construction In Progress	-	414.56	169.32	605.7	442.99	172.23

Source: S&P Global Market Intelligence. Standard template. Financial Sources.